Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

Improved insurance coverage likely drove increased adoption of Semglee (insulin glargine-yfgn) rather than its status as an interchangeable biosimilar of Lantus, according to new research published in ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

Original Medicare (Part A and Part B) does not cover insulin glargine (Basagalar). Medicare Part C and Part D cover some forms of insulin if you have diabetes, but coverage depends on the plan‘s ...

Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal insulin products in two late-stage studies, paving the way for the drug to compete with a similar weekly ...

Elevance Health, Inc. (NYSE:ELV) is a health benefits company supporting consumers’ families and communities across care journeys. It serves clients through a portfolio of medical, digital, pharmacy ...

Some advocacy groups are wondering what the P.E.I. government's change to a cheaper variety of medications over the next year will mean for patients covered by provincial prescription plans. The drugs ...

The Senate Committee on Health, Education, Labor and Pensions held a hearing last week about high prices for prescription drugs — specifically, insulin. It’s expected that they’ll roll an insulin ...